LYCOS RETRIEVER 
Anderson: M. D. Anderson
built 651 days ago
NPRL2 has been identified by the International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium, including researchers from M. D. Anderson Cancer Center, The University of Texas Southwestern Medical Center, and the National Cancer Institute. The NPRL2 gene was identified within a "genomic hotspot" of cancer causing mutations at the region of the third human chromosome termed 3p21. This region is frequently deleted or mutated in early stage lung cancer.
Source:
Sites from around the world will participate in this 1,200-patient study, with coordination and oversight by the M. D. Anderson team. The goal of the study is to compare treatment outcomes between surgery and CyberKnife radiosurgery across a broad range of geographic healthcare markets. Patient accrual is expected to begin in early 2008.
Source:
HOUSTON, May 10, 2007 /PRNewswire-FirstCall via COMTEX/ -- Tyrell, Inc., the creators of Zeno, an innovative handheld medical device used in the treatment of acne, presented a check for $15,000 to M. D. Anderson. The product that made this donation possible is one of the newest additions to the Zeno product line -- Zeno PRO.
Source:
MORE ABOUT
M. D. Anderson